Concepedia

L. Michelle Lewis

LM

17

Publications

1.1K

Citations

16

H-Index

1988

Active since

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

Johns Hopkins University

Drug Discovery Laboratory (Norway)

VA Tennessee Valley Healthcare System

L. Michelle Lewis is an author at Vanderbilt University Medical Center specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1988–2018

17

Publications

17

Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2

Eric Delpire, Emily Days, L. Michelle Lewis et al. · Proceedings of the National Academy of Sciences · 2009 · 143 citations · Full text

A Novel Selective Muscarinic Acetylcholine Receptor Subtype 1 Antagonist Reduces Seizures without Impairing Hippocampus-Dependent Learning

Douglas J. Sheffler, Richard D. Williams, Thomas M. Bridges et al. · Molecular Pharmacology · 2009 · 132 citations · Full text

Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M<sub>1</sub> Receptor Function in the Central Nervous System

Evan P. Lebois, Thomas M. Bridges, L. Michelle Lewis et al. · ACS Chemical Neuroscience · 2009 · 100 citations

, , +16

The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson’s Disease

Zixiu Xiang, Analisa D. Thompson, John T. Brogan et al. · ACS Chemical Neuroscience · 2011 · 98 citations · Full text

High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1

L. Michelle Lewis, Gautam Bhave, Brian A. Chauder et al. · Molecular Pharmacology · 2009 · 93 citations · Full text

Rows per page

1–5 of 17